Detalhe da pesquisa
1.
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.
Cancer Immunol Immunother
; 73(7): 135, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758239
2.
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study.
Ann Hematol
; 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492020
3.
Interpretation of the X-Ray Emission Spectra of Liquid Water through Temperature and Isotope Dependence.
Phys Rev Lett
; 128(8): 086002, 2022 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35275678
4.
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis.
Eur J Haematol
; 106(4): 555-562, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476404
5.
[Retrospective Analysis of Bortezomib or Lenalidomide for Very Elderly Patients with Newly Diagnosed Multiple Myeloma].
Gan To Kagaku Ryoho
; 48(6): 815-819, 2021 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-34139730
6.
Acquired Factor V Inhibitor with Hemorrhagic Symptoms after Prasugrel Hydrochloride Treatment.
Acta Haematol
; 143(5): 478-480, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522179
7.
[Spontaneous Splenic Rupture with Angioimmunoblastic T-Cell Lymphoma Successfully Treated Using Transcatheter Arterial Embolization].
Gan To Kagaku Ryoho
; 47(7): 1097-1099, 2020 Jul.
Artigo
em Japonês
| MEDLINE | ID: mdl-32668860
8.
Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12).
Int J Clin Oncol
; 24(8): 966-975, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30937622
9.
[Efficacy and Safety of Ixazomib-Lenalidomide-Dexamethasone Therapy for Relapsed and Refractory Multiple Myeloma].
Gan To Kagaku Ryoho
; 46(6): 1043-1047, 2019 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-31273172
10.
Lymphocyte-depleted classical Hodgkin lymphoma accompanied by myelofibrosis.
Rinsho Ketsueki
; 58(7): 772-775, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28781273
11.
[Usefulness of measuring serum procalcitonin levels by immunochromatographic assay in febrile neutropenia].
Rinsho Ketsueki
; 55(1): 105-9, 2014 Jan.
Artigo
em Japonês
| MEDLINE | ID: mdl-24492027
12.
Effectiveness of venetoclax and azacytidine against myeloid/natural killer cell precursor acute leukemia.
Int J Hematol
; 119(1): 88-92, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010569
13.
A case of coagulation factor V inhibitor induced by immune checkpoint inhibitor therapy.
Respirol Case Rep
; 12(2): e01307, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38356863
14.
Retrospective analysis of eltrombopag for the treatment of refractory primary immune thrombocytopenia in Japan.
Rinsho Ketsueki
; 54(5): 444-50, 2013 05.
Artigo
em Japonês
| MEDLINE | ID: mdl-23727682
15.
Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum.
Int J Hematol
; 118(5): 609-617, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668833
16.
Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin.
Sci Rep
; 13(1): 5159, 2023 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36991096
17.
Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma Forum.
Leuk Res Rep
; 20: 100395, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38076634
18.
Identification of Valence Electronic States Reflecting the Hydrogen Bonding in Liquid Ethanol.
J Phys Chem B
; 126(5): 1101-1107, 2022 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35104123
19.
Phagocytosis of Mature Granulocytes by Bone Marrow Macrophages in an Elderly Man with Adult-Onset Primary Autoimmune Neutropenia.
Hematol Rep
; 14(2): 165-171, 2022 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35735735
20.
t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity.
Biomolecules
; 12(9)2022 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36139072